Insecticides India Share Price Soars 8% on Strong Q4 Profit Growth

Market Performance

Insecticides India shares surged by 8% to Rs 895 per share on May 29, reflecting a significant jump following the company's impressive quarterly results.

• Over the last month, the stock gained 23%, significantly outperforming the Nifty 50 index, which rose by just 2% during the same period.
• This sharp rise highlights growing investor confidence in the agrochemical company's business outlook.

Strong Q4 Financial Results

The company's consolidated profit after tax (PAT) for Q4FY25 surged 85% year-on-year (YoY), climbing to Rs 13.89 Crore from Rs 7.52 Crore in Q4FY24.

Other key financial highlights for Q4FY25 include:

• Revenue from operations: Rs 358.92 Crore, up 32% YoY (Rs 272.50 Crore in Q4FY24)
• EBITDA: Rs 28.47 Crore, a remarkable 226% YoY increase (Rs 8.73 Crore a year ago)
• EBITDA margin: Expanded by 470 basis points, reaching 7.9% compared to 3.2% in the same quarter last year

These numbers reflect the company's strong operational efficiency and margin improvement.

Company Growth and Strategic Moves

Insecticides India has actively expanded its product portfolio by launching 11 new products in FY25. These include innovations based on the latest-generation patented technologies aimed at capturing a higher market share in premium segments.

The company also bolstered its supply chain by acquiring Kaeros Research Pvt. Ltd. This acquisition is set to:

• Strengthen backend operations
• Improve long-term sourcing capabilities
• Reduce costs through direct imports
• Secure critical supply chains

In addition, the company completed a buyback of 500,000 equity shares at Rs 1,000 per share, totaling Rs 50 Crore. This move reflects confidence in the company's prospects and its commitment to enhancing shareholder value.

Summary

Insecticides India's share price increased after posting strong financial performance in Q4FY25, driven by an 85% jump in profit and a 32% rise in revenue. The company's strategic initiatives, including product launches and the acquisition of Kaeros Research, further reinforce its growth trajectory.

• The stock outperformed the broader market, increasing by 23% in the last month.
• Margins improved significantly, with EBITDA soaring over twofold.
• The buyback of shares signals management's confidence in sustained growth.

Investors tracking the Insecticides India share price can note the company's clear focus on profitable growth, premium product expansion, and operational efficiency as key drivers of its recent success.